Skip to main content
TipRanks
Go Ultimate75% OFF

Amphastar Pharmaceuticals (AMPH) Q4 2022 Earnings Report

437 Followers

AMPH Q4 2022 EPS Results

Actual EPS
$0.73
Consensus EPS
$0.40
Beat/Miss
Beat by +$0.33
One Year Ago EPS
$0.42

AMPH Q4 2022 Revenue Results

Actual Revenue
$135.02M
Expected Revenue
$127.19M
Beat/Miss
Beat by +$7.84M
YoY Revenue Growth
+11.69%

Earnings Announcement Details

Quarter
Q4 2022
Date
02/28/2023
Time
After Close
Conference Call
Tuesday, February 28, 2023
AMPH Upcoming Earnings

Amphastar Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

AMPH Q4 2022 Earnings Call
0:00 / 0:00

Q4 2022 Earnings Slide Deck

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

AMPH Earnings History

AMPH earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)0.79-0.73――
Nov 05, 20262026 (Q3)0.861.140.9322.58% (+0.21)
Aug 06, 20262026 (Q2)0.620.910.857.06% (+0.06)
May 07, 20262026 (Q1)0.700.420.74-43.24% (-0.32)
Feb 26, 20262025 (Q4)0.900.730.92-20.65% (-0.19)
Nov 06, 20252025 (Q3)0.820.930.96-3.13% (-0.03)
Aug 07, 20252025 (Q2)0.740.850.94-9.57% (-0.09)
May 07, 20252025 (Q1)0.690.741.04-28.85% (-0.30)
Feb 27, 20252024 (Q4)0.940.920.884.55% (+0.04)
Nov 06, 20242024 (Q3)0.990.961.15-16.52% (-0.19)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed